Novel NF-kappa B Inhibitor Alpha Gain-of-Function Variant in an Infant with Lymphocytosis and Recurrent Serratia Bacteremia

Gunderman, L. M., Asano, T., Casanova, J. L., Boisson, B., & Khojah, A. (2023, August 1). Novel NF-kappa B Inhibitor Alpha Gain-of-Function Variant in an Infant with Lymphocytosis and Recurrent Serratia Bacteremia. Journal of Clinical Immunology. Springer. https://doi.org/10.1007/s10875-023-01481-z